Rxcurve
HCPCS J2545 · per 300 MG

Pentamidine non-comp unit

Products billed under this code include Nebupent, Pentamidine Isethionate.

Payment limit per 300 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J2545

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Nebupent FreseniUS Kabi USA, LLC 63323-0877-15 1 $67.047
Pentamidine Isethionate Seton Pharmaceuticals 13925-0522-01 1 $67.047
Pentamidine Isethionate XGen Pharmaceuticals DJB, Inc. 39822-3030-02 1 $67.047

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $67.047 −$5.95 300 MG Pentamidine non-comp unit v1, posted September 17, 2026
3Q26 $72.997 −$0.568 300 MG Pentamidine non-comp unit v1, posted September 15, 2026
2Q26 $73.565 – 300 MG Pentamidine non-comp unit v1, posted September 15, 2026
4Q25 $69.728 −$12.642 300 MG Pentamidine non-comp unit v1, posted September 8, 2026
3Q25 $82.37 +$2.873 300 MG Pentamidine non-comp unit v1, posted March 10, 2026
2Q25 $79.497 +$0.112 300 MG Pentamidine non-comp unit v1, posted March 10, 2026
1Q25 $79.385 −$6.146 300 MG Pentamidine non-comp unit v1, posted December 19, 2025
4Q24 $85.531 −$0.283 300 MG Pentamidine non-comp unit v1, posted June 11, 2025
3Q24 $85.814 −$1.283 300 MG Pentamidine non-comp unit v1, posted June 11, 2025
2Q24 $87.097 +$34.877 300 MG Pentamidine non-comp unit v1, posted March 11, 2025
1Q24 $52.22 −$40.196 300 MG Pentamidine non-comp unit v1, posted December 19, 2024
4Q23 $92.416 −$1.441 300 MG Pentamidine non-comp unit v1, posted October 10, 2024
3Q23 $93.857 +$5.493 300 MG Pentamidine non-comp unit v1, posted June 5, 2024
2Q23 $88.364 −$11.405 300 MG Pentamidine non-comp unit v1, posted February 23, 2024
1Q23 $99.769 −$7.087 300 MG Pentamidine non-comp unit v1, posted December 6, 2023
4Q22 $106.856 −$14.355 300 MG Pentamidine non-comp unit v1, posted June 22, 2023
3Q22 $121.211 −$3.116 300 MG Pentamidine non-comp unit v1, posted June 9, 2023
2Q22 $124.327 −$1.23 300 MG Pentamidine non-comp unit v1, posted December 14, 2022
1Q22 $125.557 +$1.834 300 MG Pentamidine non-comp unit v1, posted June 8, 2022
4Q21 $123.723 +$3.275 300 MG Pentamidine non-comp unit v1, posted June 2, 2022
3Q21 $120.448 +$6.339 300 MG Pentamidine non-comp unit v1, posted June 2, 2022
2Q21 $114.109 +$21.338 300 MG Pentamidine non-comp unit v1, posted March 1, 2022
1Q21 $92.771 – 300 MG Pentamidine non-comp unit v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files